Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

L Arnold Oronsky


  • Large Shareholder, Director at Pmv Pharmaceuticals Inc. (PMVP), 2020-09-24
  • Director at Dynavax Technologies Corp (DVAX), 2020-05-29
  • Large Shareholder at Avedro Inc (AVDR), 2019-11-25
  • Large Shareholder at Venus Concept Inc. (VERO), 2019-11-13
  • Director at Kalvista Pharmaceuticals Inc. (KALV), 2019-10-03
  • Large Shareholder at Obalon Therapeutics Inc (OBLN), 2019-08-08
  • Large Shareholder at Eiger Biopharmaceuticals Inc. (EIGR), 2018-10-22
  • Director at Tesaro Inc. (TSRO), 2018-08-09
  • Director at Applied Genetic Technologies Corp (AGTC), 2017-04-26
  • Large Shareholder at Glaukos Corp (GKOS), 2015-06-30
  • Large Shareholder at Invuity Inc. (IVTY), 2015-06-22
  • Large Shareholder at Marketo Inc. (MKTO), 2014-06-02
  • Director at Macrogenics Inc (MGNX), 2014-02-18
  • Large Shareholder at Transcept Pharmaceuticals Inc (TSPT), 2011-09-23
  • Other at Epocrates Inc (EPOC), 2011-02-07
  • Other at Trius Therapeutics Inc (TSRX), 2010-08-10
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
KALV $17.00 58,824 Director 388,766 2018-09-10 Filing
TSRO $35.19 142,085 Director 2,013,786 2016-03-18 Filing
AGTC $12.00 75,736 Large Shareholder, Director 1,452,216 2014-04-01 Filing
DVAX $1.08 186,047 Director 375,055 2013-10-30 Filing
TSRO $13.50 444,444 Large Shareholder, Director 3,071,701 2012-07-03 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TSRO $26.77 10,000 Director 2,479 2018-08-07 Filing
MGNX $36.50 200,000 Director 1,708,716 2014-02-18 Filing